190 filings
ARS
2023 FY
DCPH
Deciphera Pharmaceuticals Inc
25 Apr 24
Annual report to shareholders
4:43pm
DEFA14A
DCPH
Deciphera Pharmaceuticals Inc
25 Apr 24
Additional proxy soliciting materials
4:38pm
DEF 14A
DCPH
Deciphera Pharmaceuticals Inc
Definitive proxy
25 Apr 24
7:10am
PRER14A
DCPH
Deciphera Pharmaceuticals Inc
22 Apr 24
Preliminary revised proxy
7:10am
PRE 14A
DCPH
Deciphera Pharmaceuticals Inc
11 Apr 24
Preliminary proxy
7:10am
S-8
hvd89xrw
7 Feb 24
Registration of securities for employees
7:52am
8-K
a0b2gr7643590
6 Feb 24
Deciphera Pharmaceuticals Announces Fourth Quarter and Full Year 2023 Financial Results
7:10am
8-K
ajm2csh
8 Jan 24
Deciphera Pharmaceuticals Announces Planned 2024 Corporate Milestones Supporting Evolution to a Self-Sustaining, Multi-Product Company
7:14am
UPLOAD
8dp v52n8m011z9v9o6
2 Jan 24
Letter from SEC
12:00am
CORRESP
lap7ea0
22 Dec 23
Correspondence with SEC
12:00am
UPLOAD
8inn9ch9ywx0 xpoka
14 Dec 23
Letter from SEC
12:00am
8-K
m2ep2sfbv
30 Oct 23
Deciphera Pharmaceuticals Announces Third Quarter 2023 Financial Results
7:06am
8-K
6mkkl zzfzj
9 Aug 23
Deciphera Pharmaceuticals Announces Second Quarter 2023 Financial Results
7:06am
8-K
s7r35409rtc 5orge
3 Aug 23
Deciphera Pharmaceuticals Announces Retirement of Daniel L. Flynn, Ph.D., and Appointment of
4:20pm
8-K
fune 9avh9bdn
22 Jun 23
Submission of Matters to a Vote of Security Holders
4:06pm
S-3ASR
jkhbo3o10iqv00gs9xk
3 May 23
Automatic shelf registration
8:45am